Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Applied Therapeutics Inc (NASDAQ: APLT) closed at $0.47 in the last session, up 3.24% from day before closing price of $0.46. In other words, the price has increased by $3.24 from its previous closing price. On the day, 0.9 million shares were traded. APLT stock price reached its highest trading level at $0.4779 during the session, while it also had its lowest trading level at $0.4438.
Ratios:
We take a closer look at APLT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.00 and its Current Ratio is at 3.00. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On December 02, 2024, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $13 to $2.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on November 29, 2024, whereas the target price for the stock was revised from $12 to $4.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 04 ’25 when Perfetti Riccardo sold 10,366 shares for $0.44 per share. The transaction valued at 4,561 led to the insider holds 890,409 shares of the business.
Funtleyder Leslie D. sold 14,502 shares of APLT for $6,381 on Mar 04 ’25. The insider now owns 390,459 shares after completing the transaction at $0.44 per share. On Mar 04 ’25, another insider, Chinoporos Constantine, who serves as the insider of the company, sold 447 shares for $0.44 each. As a result, the insider received 197 and left with 271,436 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLT now has a Market Capitalization of 67234440 and an Enterprise Value of 19172218. For the stock, the TTM Price-to-Sale (P/S) ratio is 249.00 while its Price-to-Book (P/B) ratio in mrq is 1.83. Its current Enterprise Value per Revenue stands at 72.348 whereas that against EBITDA is -0.176.
Stock Price History:
The Beta on a monthly basis for APLT is 1.96, which has changed by -0.90935117 over the last 52 weeks, in comparison to a change of 0.16260707 over the same period for the S&P500. Over the past 52 weeks, APLT has reached a high of $10.62, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is 21.04%, while the 200-Day Moving Average is calculated to be -79.27%.
Shares Statistics:
According to the various share statistics, APLT traded on average about 2.33M shares per day over the past 3-months and 1701540 shares per day over the past 10 days. A total of 141.58M shares are outstanding, with a floating share count of 116.52M. Insiders hold about 17.70% of the company’s shares, while institutions hold 74.84% stake in the company. Shares short for APLT as of 1751241600 were 18077667 with a Short Ratio of 7.76, compared to 1748563200 on 18011669. Therefore, it implies a Short% of Shares Outstanding of 18077667 and a Short% of Float of 12.86.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
A detailed examination of Applied Therapeutics Inc (APLT) is currently in progress, with 3.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.09 and low estimates of -$0.17.
Analysts are recommending an EPS of between -$0.46 and -$0.66 for the fiscal current year, implying an average EPS of -$0.59. EPS for the following year is -$0.54, with 3.0 analysts recommending between -$0.26 and -$0.71.
